$18.60
+0.70 (+3.88%)
Analyst Consensus
Strong Buy
22
Analysts
High
Coverage
Price Target
Analyst Price Target
+606.9% upside
Low Target
$82.08
Average Target
$131.49
High Target
$141.61
Current Price
$18.60
Current
$18.60
$18.60
Target
$131.49
$131.49
$82.08
$131.49 avg
$141.61
Scenario Analysis
Bear Case
$82.08
341.3%
Low target
Base Case
$131.49
+606.9%
Avg target
Bull Case
$141.61
+661.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$30.06
-38.1% from high
52-Week Low
$14.64
+27.0% from low
50-Day SMA
$21.49
-13.4% vs SMA
200-Day SMA
$22.37
-16.9% vs SMA
RSI (14)
61.3
Neutral
Target vs 52W High
$131.49
+337.4% vs high
Next Earnings Report
Nov 16, 2026
8d
until earnings
EPS Est: $-0.64
Earnings in 8 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -11.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +117.3% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -19.9% |
| MRNA | Hold | 31 | 35% | $149.45 | -41.2% |
| REGN | Buy | 37 | 70% | $76.80 | -91.5% |
| NTRA | Strong Buy | 30 | 90% | $142.91 | -54.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -40.7% |